

Publisher: Bentham Science Publishers
E-ISSN: 1875-6018|7|4|245-248
ISSN: 1871-5214
Source: Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol.7, Iss.4, 2008-10, pp. : 245-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Telbivudine: A Review of its Use in Compensated Chronic Hepatitis B
Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. :




Telbivudine for chronic hepatitis B: the GLOBE trial
By Yuen Man-Fung Lai Ching-Lung
Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. :